Clinical Trials Browser

Phase 2 × Interventional × Extranodal Extension × Clear all

NCT05816746 2023-05-09

Decitabine and Anti-PD-1 in R/R DLBCL

Phase 2 Unknown

Extranodal Extension, Recurrence, Lymphoma, Large B-Cell, Diffuse